Effect of herbal medicine containing Saatar, Hofarigon and Fennel on COVID-19 patients

Phase 3

Recruiting

• Conditions: COVID-19.; Coronavirus infection, unspecified; B34.2

• Registration Number: IRCT20200404046935N1
• Lead Sponsor: Mazandaran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 18 May 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Temperatures above 2 degrees
Lymphocyte count less than 2
CRP positive
Respiratory symptoms
Symptoms of pulmonary involvement in CT scan
Satisfaction to participate in the study
Age older than 18 years

Exclusion Criteria

Oral intolerance
Pulmonary disease

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Fever. Timepoint: Every day for 7 days. Method of measurement: termometer.;Lymphocyte count. Timepoint: Before and 7 days after intervention. Method of measurement: Cell counter device.;Erythrocyte sedimentation rate. Timepoint: Before and 7 days after intervention. Method of measurement: ESR device.

Secondary Outcome Measures

Name	Time	Method
Pneumonia. Timepoint: Before and 14 days after intervention. Method of measurement: CT-Scan.